Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
about
The emerging role of immunotherapy in colorectal cancerTrial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapyNovel Immunotherapeutic Approaches for Head and Neck Squamous Cell CarcinomaA novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.Trial Watch: Toll-like receptor agonists for cancer therapy.Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy.Toll-Like Receptor 9 Agonists for Cancer Therapy.Open-label phase 1b study of FOLFIRI plus cetuximab plus IMO-2055 in patients with colorectal cancer who have progressed following chemotherapy for advanced or metastatic disease.
P2860
Q28067898-6392714A-33BE-429D-BDE6-48B67FDC2791Q28067939-1261B290-452A-4370-895E-8410523C8004Q28071998-173DC141-DB6A-4CCE-A10C-68EEC2440DCAQ38926456-C928595F-22A4-4519-A31D-341178F1653BQ42969291-10E43A2D-76A3-45DC-9670-81FE44180B41Q43974504-FEF3CE4A-2D13-468D-810E-364ED17441E4Q50863800-C1077CA8-0E25-4F7A-8014-F3A1A854006CQ52972104-BB881157-7FBB-4278-91A9-24C8A7C426EB
P2860
Phase Ib trial of the Toll-like receptor 9 agonist IMO-2055 in combination with 5-fluorouracil, cisplatin, and cetuximab as first-line palliative treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Phase Ib trial of the Toll-lik ...... arcinoma of the head and neck.
@en
Phase Ib trial of the Toll-lik ...... arcinoma of the head and neck.
@nl
type
label
Phase Ib trial of the Toll-lik ...... arcinoma of the head and neck.
@en
Phase Ib trial of the Toll-lik ...... arcinoma of the head and neck.
@nl
prefLabel
Phase Ib trial of the Toll-lik ...... arcinoma of the head and neck.
@en
Phase Ib trial of the Toll-lik ...... arcinoma of the head and neck.
@nl
P2093
P2860
P1476
Phase Ib trial of the Toll-lik ...... arcinoma of the head and neck.
@en
P2093
Jean-Pascal Machiels
Jean-Pierre Delord
Marie-Christine Kaminsky
Thomas Goddemeier
Tim H Brümmendorf
Ulf Forssmann
Ulrich Keller
P2860
P2888
P304
P356
10.1007/S10637-013-9933-Z
P577
2013-02-10T00:00:00Z
P5875
P6179
1004702004